Selitrectinib (BAY2731954)
Sponsors
Bayer
Conditions
Solid Tumors Harboring NTRK Fusion
Phase 1
A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
CompletedNCT03215511
Start: 2017-07-03End: 2023-01-30Updated: 2024-10-30
Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body
CompletedNCT04275960
Start: 2020-02-28End: 2020-11-30Updated: 2020-12-29